Detecting Beta-amyloid in the Retina
NCT: NCT07529912 · TERMINATED
Brief Summary
Hyperspectral retinal imaging is a non-invasive imaging modality in which a series of images of the retina are captured using light of different wavelengths. The resulting "hypercube" of data provides detailed information about retinal structure. Previous research has demonstrated a potential role for this technology in the detection of retinal amyloid beta in Alzheimer's disease. This study aims to further evaluate the use of hyperspectral retinal imaging in the assessment of individuals with dementia or those at risk of Alzheimer's disease.
Frequently Asked Questions
What is Detecting Beta-amyloid in the Retina?
Detecting Beta-amyloid in the Retina is a clinical trial registered under NCT07529912. Current status: TERMINATED.
What is the status of NCT07529912?
The current status of NCT07529912 (Detecting Beta-amyloid in the Retina) is: TERMINATED.
When did Detecting Beta-amyloid in the Retina start?
Detecting Beta-amyloid in the Retina started on 2016-02-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.